Experts in Bay Area Disclose Why Early Stage Companies Need to Have a Reimbursement Strategy

Overview


Dr. Paul Radenskyspoke at an event hosted by BioCom about reimbursement of new healthcare technologies. He said companies need to have parallel tracks of product development, regulatory pathway development and reimbursement strategy development running simultaneously.